Dow Jones & Company, Inc. and NYP Holdings, Inc. v. Perplexity AI, Inc. -
Plaintiffs Dow Jones and Company, Inc. and NYP Holdings, Inc., publishers of The Wall Street Journal and New York Post, (collectively, Plaintiffs),...more
11/20/2024
/ Artificial Intelligence ,
Commercial Litigation ,
Copyright ,
Copyright Infringement ,
Damages ,
False Designation of Origin ,
Intellectual Property Protection ,
IP Litigation ,
Machine Learning ,
Technology Sector ,
Trademarks
The US Patent Office (USPTO) recently issued new guidance and three examples for AI-related patent claims, which indicate that claims applying AI to a process are unlikely to render the process patent-eligible at the USPTO...more
8/7/2024
/ Artificial Intelligence ,
Innovative Technology ,
Intellectual Property Protection ,
Inventions ,
Inventors ,
New Guidance ,
Patent Applications ,
Patent-Eligible Subject Matter ,
Patents ,
Section 101 ,
Technology ,
USPTO
A split Supreme Court has decided that, under a plain reading of the Copyright Act, a party alleging copyright infringement may obtain damages for the entire damages period, so long as the suit itself is timely brought....more
5/15/2024
/ Appeals ,
Copyright ,
Copyright Infringement ,
Copyright Litigation ,
Damages ,
Discovery Rule ,
Intellectual Property Litigation ,
Intellectual Property Protection ,
Music Industry ,
SCOTUS ,
Statute of Limitations ,
The Copyright Act ,
Warner Chappell Music v Nealy
Artificial intelligence (AI) has dominated the headlines over the last several years. As technology has continued to advance, computers and robots have progressed from merely assisting human beings with common tasks to making...more
While the humanitarian crisis has received the most attention during the emerging situation in Ukraine, numerous other facets of the world economy, international relations, and daily life have also been affected. One...more
Strong brands are prime targets for trademark scams in times of crisis like the COVID-19 pandemic because of the trust and goodwill they have built with the consuming public. Brands in the medical products sphere should be on...more
President Trump has signed Phase I of a much anticipated multi-part trade agreement between the United States and China with provisions that will aid the branded pharmaceutical industry. One of the main goals of the agreement...more
1/23/2020
/ China ,
Counterfeit Drugs ,
Criminal Liability ,
Dispute Resolution ,
Generic Drugs ,
Hatch-Waxman ,
Injunctive Relief ,
Intellectual Property Protection ,
Patent Infringement ,
Patents ,
Pharmaceutical Industry ,
Prescription Drugs ,
Trade Agreements ,
Trade Secrets ,
Trump Administration ,
US Trade Policies
The Defend Trade Secrets Act, signed into law on May 11, 2016, includes a whistleblower immunity notice provision. An employer that wants to preserve maximum recoveries for misappropriation against an employee should take...more
5/19/2016
/ Attorney's Fees ,
Confidential Information ,
Damages ,
Defend Trade Secrets Act (DTSA) ,
Employees ,
Employment Contract ,
Immunity ,
Independent Contractors ,
Intellectual Property Protection ,
Misappropriation ,
New Legislation ,
Notice Requirements ,
Trade Secrets ,
Whistleblower Protection Policies
As expected, overwhelming support for the Defend Trade Secrets Act of 2016 led to its passage in the U.S. House of Representatives yesterday by a 410-2 vote. During the floor debate, one Congressman noted that “Congress has...more
4/29/2016
/ Asset Seizure ,
Defend Trade Secrets Act (DTSA) ,
Employment Contract ,
Ex Parte ,
Intellectual Property Protection ,
Misappropriation ,
Pending Legislation ,
Private Right of Action ,
Remedies ,
Trade Secrets ,
Whistleblower Protection Policies
The U.S. Senate has unanimously approved a bill increasing the protections available to companies for their commercial secrets. The Defend Trade Secrets Act of 2016 (DTSA or the Act) provides for the first time a truly...more
4/12/2016
/ Corporate Counsel ,
Defend Trade Secrets Act (DTSA) ,
Employment Contract ,
Intellectual Property Protection ,
Misappropriation ,
Pending Legislation ,
Popular ,
Private Right of Action ,
Remedies ,
Trade Secrets ,
Uniform Trade Secrets Acts ,
Whistleblower Protection Policies